Kentucky
General Assembly

11/19/20	Prefiled by the sponsor(s).
01/05/21	introduced in House to Committee on Committees (H)
02/02/21	to Health & Family Services (H)
02/10/21	posted in committee
02/11/21	reported favorably, 1st reading, to Calendar with Committee Substitute
02/22/21	2nd reading, to Rules posted for passage in the Regular Orders of the Day for Tuesday, February 23, 2021
02/23/21	3rd reading, passed 95-0 with Committee Substitute
02/24/21	received in Senate to Committee on Committees (S)
02/26/21	to Banking & Insurance (S)
03/02/21	reported favorably, 1st reading, to Consent Calendar with Committee Substitute (1) floor amendment (1) filed to Committee Substitute, floor amendment (2) filed to bill
03/03/21	2nd reading, to Rules posted for passage in the Regular Orders of the Day for Friday, March 5, 2021
03/04/21	floor amendment (3) filed to Committee Substitute
03/05/21	3rd reading floor amendment (1) withdrawn passed 35-0 with Committee Substitute and floor amendments (3) and (2-title)
03/11/21	received in House to Rules (H)
03/12/21	taken from Rules posted for passage for concurrence in Senate Committee Substitute and floor amendments (3) and (2-title) House refused to concur in Senate Committee Substitute, floor amendments (3) and (2-title)
03/15/21	received in Senate to Rules (S) posted for passage for receding from Senate Committee Substitute, and floor amendments (3) and (2-title) for Tuesday, March 16, 2021
03/16/21	Senate receded from Committee Substitute (1) and floor amendments (2-title) and (3) Bill passed 36-0 received in House enrolled, signed by Speaker of the House enrolled, signed by President of the Senate delivered to Governor
03/22/21	signed by Governor (Acts Ch. 75)

Amendment	House Committee Substitute 1
Fiscal Impact Statement	Health Mandate to House Committee Substitute 1
Summary	Retain original provisions; delete provision prohibiting an insurer with a cost-sharing requirment of less than $30 for a 30 day supply of prescription inuslin on the effective date of this Act from increasing that cost-sharing requirement; define "cost sharing."
Index Headings	Diseases - Prescription insulin drugs, cost sharing, cap Drugs and Medicines - Prescription insulin drugs, cost sharing, cap Effective Dates, Delayed - Prescription insulin drugs, cost sharing, January 1, 2022 Health Benefit Mandate - Prescription insulin drugs, cost sharing, cap Insurance, Health - Prescription insulin drugs, cost sharing, cap

Amendment	Senate Committee Substitute 1
Fiscal Impact Statement	Health Mandate to Senate Committee Substitute 1
Summary	Retain original provisions; increase cap on cost-sharing requirements for prescription insulin to $35 for a 30 day supply; EFFECTIVE January 1, 2022.
Index Headings	Diseases - Diabetes, prescription insulin drugs, cost sharing, cap Drugs and Medicines - Prescription insulin drugs, cost sharing, cap Effective Dates, Delayed - Prescription insulin drugs, cost sharing, January 1, 2022 Insurance, Health - Prescription insulin drugs, cost sharing, cap Health Benefit Mandate - Prescription insulin drugs, cost sharing, cap

Amendment	Senate Floor Amendment 1
Sponsor	J. Carpenter
Summary	Delete delayed effective date and replace with emergency clause. EMERGENCY.
Index Headings	Effective Dates, Emergency - Prescription insulin drugs, cost sharing, cap

Amendment	Senate Floor Amendment 2
Sponsor	J. Carpenter
Summary	Make title amendment.
Index Headings	Title Amendments - HB 95/GA

Amendment	Senate Floor Amendment 3
Sponsor	J. Carpenter
Summary	Provide that section on diabetes coverage is subject to federal law and regulations; delete delayed effective date and replace with emergency clause. EMERGENCY.
Index Headings	Federal Laws and Regulations - Health benefit plans, diabetes, coverage Effective Dates, Emergency - Prescription insulin drugs, cost sharing, cap